Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
CLVT 
CLARIVATE PLC (CLVT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: CLVT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $5.31
1 Year Target Price $5.31
| 3 | Strong Buy |
| 2 | Buy |
| 4 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -53.11% | Avg. Invested days 37 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.94B USD | Price to earnings Ratio - | 1Y Target Price 5.31 |
Price to earnings Ratio - | 1Y Target Price 5.31 | ||
Volume (30-day avg) 10 | Beta 1.48 | 52 Weeks Range 3.04 - 7.15 | Updated Date 06/30/2025 |
52 Weeks Range 3.04 - 7.15 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.97 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -26.32% | Operating Margin (TTM) 5.21% |
Management Effectiveness
Return on Assets (TTM) 1.2% | Return on Equity (TTM) -12.2% |
Valuation
Trailing PE - | Forward PE 6.63 | Enterprise Value 7185404513 | Price to Sales(TTM) 1.16 |
Enterprise Value 7185404513 | Price to Sales(TTM) 1.16 | ||
Enterprise Value to Revenue 2.84 | Enterprise Value to EBITDA 16.65 | Shares Outstanding 683086976 | Shares Floating 409503762 |
Shares Outstanding 683086976 | Shares Floating 409503762 | ||
Percent Insiders 16.46 | Percent Institutions 93 |
Analyst Ratings
Rating 4 | Target Price 5.31 | Buy 2 | Strong Buy 3 |
Buy 2 | Strong Buy 3 | ||
Hold 4 | Sell 1 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
CLARIVATE PLC
Company Overview
History and Background
Clarivate was formed in 2016 from the Intellectual Property and Science business of Thomson Reuters. It became a public company in 2019 through a merger with Churchill Capital Corp, a special purpose acquisition company (SPAC). The company provides data and analytics solutions to accelerate the pace of innovation.
Core Business Areas
- Science: Provides scientific and academic research information and analytics, including Web of Science.
- Intellectual Property: Offers solutions for managing intellectual property, including patent data and trademark searches.
- Life Sciences & Healthcare: Provides data and insights to the pharmaceutical and biotechnology industries.
Leadership and Structure
Clarivate is led by a CEO (Jonathan Gear), and has a structured organizational hierarchy with distinct divisions for each business area. The board of directors oversees strategic direction.
Top Products and Market Share
Key Offerings
- Number of Users: Unknown
- Revenue: Information not publicly available
- Web of Science: A subscription-based online scientific citation indexing service. Market share is difficult to determine precisely, but it's a leading academic citation database. Competitors include Scopus (Elsevier) and Google Scholar.
- Derwent Innovation: A patent intelligence platform. Market share is significant but not precisely quantified. Competitors include PatSnap and Questel.
- Number of Users: Unknown
- Revenue: Information not publicly available
- Cortellis: A suite of life science intelligence solutions. Competitors include EvaluatePharma and GlobalData.
- Number of Users: Unknown
- Revenue: Information not publicly available
Market Dynamics
Industry Overview
The market for scientific and intellectual property information is growing, driven by increased R&D spending, globalization, and the need for efficient knowledge management.
Positioning
Clarivate is a major player in the industry, providing comprehensive data and analytics solutions to academic, corporate, and government clients. It differentiates itself through its extensive content coverage and integrated solutions.
Total Addressable Market (TAM)
The TAM is estimated to be in the tens of billions of dollars, encompassing research databases, patent analytics, and life sciences intelligence. Clarivate holds a significant portion of this TAM and aims to expand its reach through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Extensive data assets
- Integrated solutions
- Established customer base
Weaknesses
- High debt levels
- Integration challenges from acquisitions
- Competition from specialized vendors
- Complex product offerings
Opportunities
- Growing demand for research data
- Expansion into new geographic markets
- Development of AI-powered analytics
- Strategic acquisitions
Threats
- Economic downturns
- Emergence of disruptive technologies
- Increased competition
- Changes in regulatory environment
Competitors and Market Share
Key Competitors
- RELX
- ELS
- MDGN
Competitive Landscape
Clarivate faces competition from larger diversified information providers and specialized vendors. Clarivate aims to differentiate through its comprehensive data and analytics offerings and its strong brand recognition.
Major Acquisitions
ProQuest (Information technology company)
- Year: 2021
- Acquisition Price (USD millions): 5300
- Strategic Rationale: Expanded content and capabilities in research and education.
Growth Trajectory and Initiatives
Historical Growth: Growth has been driven by acquisitions and organic expansion of its product offerings.
Future Projections: Analyst projections vary. Consensus estimates suggest moderate revenue growth.
Recent Initiatives: Focus on integrating acquired companies and developing new AI-powered solutions.
Summary
Clarivate is a major player in the information services industry, offering valuable data and analytics to a diverse customer base. While the company benefits from its strong brand and extensive content, it faces challenges related to debt, integration, and competition. Recent acquisitions have significantly expanded its capabilities, positioning it for future growth. However, it needs to manage its debt and competitive pressures to achieve its long-term goals.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Analyst Reports
- Industry Publications
Disclaimers:
The information provided is for informational purposes only and should not be construed as financial advice. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CLARIVATE PLC
Exchange NYSE | Headquaters - | ||
IPO Launch date 2018-10-29 | CEO & Director Mr. Matitiahu Shem Tov | ||
Sector Technology | Industry Information Technology Services | Full time employees 12000 | Website https://www.clarivate.com |
Full time employees 12000 | Website https://www.clarivate.com | ||
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.